Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SIX
1851
DELISTED
Six Flags Entertainment Corp.
SIX
| $4.47M | ﹤0.01% |
+88,100
| New | +$4.78M |
|
|
ALSK
1852
DELISTED
Alaska Communications Systems
ALSK
| $4.47M | ﹤0.01% |
2,596,480
+166,210
| +7% | +$295K |
|
1853
Hurco Companies Inc
HURC
$135M
| $4.46M | ﹤0.01% |
138,582
+32,100
| +30% | +$1.07M |
|
|
OPB
1854
DELISTED
Opus Bank Common Stock
OPB
| $4.46M | ﹤0.01% |
204,704
+69,594
| +52% | +$1.48M |
|
1855
LSI Industries
LYTS
$859M
| $4.45M | ﹤0.01% |
851,571
+155,826
| +22% | +$662K |
|
1856
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.37B
| $4.44M | ﹤0.01% |
40,800
+10,000
| +32% | +$1.08M |
|
1857
Jack in the Box
JACK
$312M
| $4.44M | ﹤0.01% |
48,700
-136,000
| -74% | -$11.3M |
|
|
EXFO
1858
DELISTED
EXFO INC.
EXFO
| $4.44M | ﹤0.01% |
1,111,840
-61,729
| -5% | -$233K |
|
1859
Nature's Sunshine
NATR
$354M
| $4.43M | ﹤0.01% |
534,821
+25,500
| +5% | +$232K |
|
1860
ICL Group
ICL
$6.53B
| $4.43M | ﹤0.01% |
884,175
-94,412
| -10% | -$471K |
|
1861
Rocky Mountain Chocolate Factory
RMCF
$7.93M
| $4.43M | ﹤0.01% |
476,101
-822
| -0.2% | -$7.36K |
|
1862
Apyx Medical
APYX
$173M
| $4.42M | ﹤0.01% |
652,800
-13,800
| -2% | -$97.9K |
|
|
PFBI
1863
DELISTED
Premier Financial Bancorp
PFBI
| $4.41M | ﹤0.01% |
256,888
+35,200
| +16% | +$557K |
|
1864
PTC Therapeutics
PTCT
$5.68B
| $4.41M | ﹤0.01% |
130,300
-238,760
| -65% | -$10.4M |
|
1865
First Financial Bancorp
FFBC
$3.55B
| $4.4M | ﹤0.01% |
179,880
-192,200
| -52% | -$4.64M |
|
|
SOHO
1866
DELISTED
Sotherly Hotels
SOHO
| $4.4M | ﹤0.01% |
658,147
+58,413
| +10% | +$401K |
|
1867
Xenon Pharmaceuticals
XENE
$6.06B
| $4.4M | ﹤0.01% |
488,600
+13,100
| +3% | +$124K |
|
|
ECHO
1868
DELISTED
Echo Global Logistics, Inc.
ECHO
| $4.4M | ﹤0.01% |
194,300
+113,200
| +140% | +$2.34M |
|
|
EGLE
1869
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $4.39M | ﹤0.01% |
143,313
-19,542
| -12% | -$649K |
|
|
AGTC
1870
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $4.37M | ﹤0.01% |
1,051,060
+93,260
| +10% | +$337K |
|
1871
iShares National Muni Bond ETF
MUB
$45.1B
| $4.36M | ﹤0.01% |
38,181
-46,900
| -55% | -$5.35M |
|
|
GEN
1872
DELISTED
Genesis Healthcare, Inc.
GEN
| $4.35M | ﹤0.01% |
3,921,530
+247,419
| +7% | +$286K |
|
|
MTLS
1873
Materialise
MTLS
$368M
| $4.35M | ﹤0.01% |
235,500
-20,900
| -8% | -$389K |
|
1874
Cass Information Systems
CASS
$714M
| $4.35M | ﹤0.01% |
80,489
-35,360
| -31% | -$1.81M |
|
1875
Seres Therapeutics
MCRB
$46.8M
| $4.33M | ﹤0.01% |
53,960
+1,790
| +3% | +$118K |
|
Similar funds
Renaissance Technologies's Q3 2019 Portfolio in Review
As of Q3 2019, Renaissance Technologies held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Renaissance Technologies's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Renaissance Technologies added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Renaissance Technologies's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Renaissance Technologies fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Renaissance Technologies's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Renaissance Technologies opened 406 new positions and closed 522 in Q3 2019.
- Renaissance Technologies's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.